ArticleOncology letters2026
Salivary duct carcinoma with heterotopic ossification in the parotid gland: A case report.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lymphoplasmacytic Lymphoma Involving Marrow-Containing Submandibular Heterotopic Ossification: A Case Report and Literature Review.Head and neck pathology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salivary duct carcinoma (SDC) is one of the most aggressive salivary gland carcinomas. Heterotopic ossification (HO) is the formation of mature bone in non-skeletal tissues. HO can occur in a number of neoplastic lesions. However, its occurrence is markedly rare in salivary gland neoplasms and to the best of our knowledge, SDC with HO has not yet been reported. Therefore, the present report describes the first reported case of SDC with HO in the parotid gland and reviews the clinicopathological features of salivary gland neoplasms with HO. A 38-year-old Japanese male presented with a mass in the left parotid region. Physical examination revealed a poorly mobile mass, measuring 2 cm, in the left parotid gland. Total left parotidectomy was performed. A number of metastases were observed in the bone and brain, despite postoperative anti-HER2 combination chemotherapy. Histopathological examination of the resected parotid gland tumour revealed invasive neoplastic growth comprising cribriform and papillary proliferations. These neoplastic cells exhibited a rich eosinophilic cytoplasm and large nuclei containing conspicuous nucleoli. In addition, the present report outlines peculiar finding in the presence of mature bone tissue within the tumour. Accordingly, a diagnosis of SDC with HO was made. Despite the detailed mechanisms underlying the occurrence of HO in salivary gland neoplasms remaining unclear, neoplastic myoepithelial cells may serve a role in the development of HO in pleomorphic adenoma and carcinoma ex pleomorphic adenoma. However, SDC exhibited no myoepithelial cell components, therefore the mechanism of HO in SDC may differ from that in PA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.